Objective: The use of low-dose aspirin for primary prevention of cardiovascular events in
patients at elevated risk for cardiovascular disease (CVD) is increasingly being questioned …

Background Aspirin use has been shown to be an effective tool in cardiovascular disease
(CVD) prevention among high‐risk patients. The patient‐reported physician …

Background: Among patients without cardiovascular disease (CVD) and low 10-year CVD
risk, the risks of gastrointestinal bleeding and hemorrhagic strokes associated with aspirin …

ABSTRACT BACKGROUND The United States Preventive Services Task Force (USPSTF)
released updated guidelines in 2009 recommending aspirin to prevent myocardial infarction …

Introduction Daily aspirin use for primary cardiovascular disease prevention is common
among adults. Numerous clinical trials observe reduced cardiovascular disease with regular …

Introduction: Aspirin is an effective anti-inflammatory and antiplatelet agent as an irreversible
inhibitor of cyclooxygenase. In 2016, the US Preventive Services Task Force recommended …

Background: Cardiovascular disease (CVD) is the leading cause of death in the United
States. Purpose: To update a systematic review about the benefits of aspirin for the primary …

Background Despite the proven benefits of aspirin therapy in the primary and secondary
prevention of cardiovascular disease (CVD), utilization rates of aspirin remain suboptimal in …

Background No previous study has evaluated the impact of past US Preventive Services
Task Force statements on primary prevention (PP) aspirin use in a primary care setting. The …

Over the past decades, the medical community has witnessed a significant improvement in
cardiovascular disease (CVD) outcomes. Nonetheless, CVD remains a leading cause of …